CDA Catalyst Grant and Short-Term Fellowship
Learn more about the CDA Catalyst Grant and Short-Term Fellowship
CDA Catalyst Grant
The Catalyst Grant, funded by the Ministry of Health, was administered by the National Centre for Infectious Diseases (NCID) from 2018 to 2024. Since April 2025, with the establishment of Communicable Diseases Agency (CDA), Catalyst Grant has been officially administered by CDA. It aims to promote inter-institutional research collaboration in infectious diseases and public health, focusing on Health and Biomedical Sciences (HBMS) priority areas which include antimicrobial resistance, vector-borne diseases, respiratory infections, and human immunodeficiency virus.
The grant supports young or new principal investigators in building partnerships between clinician scientists and researchers from hospitals and research institutions. Through these collaborations, the CDA Catalyst Grant facilitates strategic and innovative clinical and public health research within Singapore.
The FY2026 CDA Catalyst Grant is now open for application. Please refer to the information below on how to apply. The grant call will close on 27 February 2026, 6pm.
Eligibility
Interested researchers based in Singapore and working in the above HBMS infectious disease priority areas are welcome to apply. Awardees who are funded in earlier FYs will not be supported.
The Lead Principal Investigator should:
Hold a primary appointment in either a public health institution, national specialty centre, university/academic medical centre, and be receiving a salary from the aforesaid institution or centre, throughout the period of the grant.
Note:
The Grants are targeted at junior investigators. Applicants with substantial research experience should not apply as Lead Principal Investigator under this grant category, although they may be included in a mentoring or supervisory capacity.
Priority will be given to Lead Principal Investigators who have seven years or less research experience after PhD or advanced specialty clinical training
Fund Details
The funding quantum is up to a maximum of S$50,000 per project (no indirect cost will be supported).
Funds are up to a maximum period of twelve (12) months, and the Lead PI should have an awareness of the feasibility to complete the study within this timeframe, and this includes fulfilling the ethics and research agreement requirements.
Application procedure
Interested applicants are invited to complete the ‘Catalyst Grant - Application Form’, and submit (i) a single Microsoft Word document, without signatures, and (ii) a single PDF document, with signatures, through their Institutional Research Office to the grant secretariat (RCA_Grants@cda.gov.sg) by 6pm, 27 February 2026 (Friday).
Please contact the RCA Grant Secretariat for the application form.
Each applicant can only submit one application. The application must list all the people and groups involved in the project.
The submission should meet one or more of the following objectives:
Develop and strengthen inter-institutional research collaborations or networks within Singapore.
Facilitate partnership between Singaporean researchers and researchers working elsewhere in Asia.
Provide pilot data or a platform to launch or advance innovative new research projects that meet the broad goals of the HBMS infectious disease priority areas.
Applications must be endorsed by the institutional authorities (e.g., Department Head, Director of Research or equivalent), to ensure institutional support, ownership, and oversight of the project.
Applications proposing inter-departmental collaborations within the same organisation will not be considered for funding.
Contact details
RCA Grant Secretariat: RCA_Grants@cda.gov.sg
Additional information
Please refer to the attached file for more information.
Guidelines for the Management of Catalyst Grant
All claims will be processed strictly on reimbursement basis and are subjected to the grantor’s prevailing finance policies that may be modified at any time by the grantor. However, all grantees will be notified if there are changes to the financial policies.
FY2026 CDA Catalyst Grant - Awarded Projects
FY2026 CDA Catalyst Grant - Awarded Projects | ||
Principal Investigator | Project Title | Host Institution |
Dr Chu Hon Weng Wilson | Investigating the interplay of bacterial and host heme oxygenases in Klebsiella pneumoniae bloodstream infection | A*STAR IDL |
Dr Louis DeFalco | Structure-based Predictive Modelling of Epidemic Risk in Vector-borne Diseases | A*STAR BII |
Asst Prof Cai Yiying | Estimating the Economic Burden of Healthcare-Associated Infections across Health Systems in Asia | Duke-NUS |
Dr Srishti Chhabra | Understanding the pathophysiology and molecular genetics of uropathogenic Escherichia coli in catheter associated urinary tract infections | NUH |
Dr Andre Mong Jie Ng | Understanding baseline cross-neutralising H5 Antibody Responses in Seasonal Influenza Patients | A*STAR IDL |
Dr Sophie Wilhelmina van Leur | A CRISPR-Engineered Nasal Organoid Platform To Dissect Membrane-bound Mucin Restriction Of Respiratory Viruses | Duke-NUS |
Dr Micaela Mossop | Using the hollow fibre infection model for development of novel antibiotic combinations | NTU |
Dr Cherie Gan Le Si | "RSV-CLEAR" (RSV Culture and PCR Cp Value Evaluation for Assessing Risk of Infectivity in Immunocompromised Hosts) | SGH |
CDA Short-Term Fellowship
The Communicable Diseases Agency (CDA) Short-Term Fellowship is funded by the Ministry of Health. It was formerly known as the Short-Term Fellowship and administered by NCID from 2018 to 2024. The grant enables active infectious disease researchers to either host international collaborators and experts in Singapore or undertake research training attachments at leading overseas institutions. Through these exchanges, the programme fosters international collaboration and develops research capabilities.
The FY2026 CDA Short-Term Fellowship is now open for application. Please refer to the information below on how to apply. The call will close on 30 June 2026, 6pm.
Eligibility
Applicants should be ID researchers in a local institution who have demonstrated current active research (e.g. approved projects, awarded grants, publications) in the area of the proposed visit. Applicants who have previously been the recipient of any Short-Term Fellowship awarded by the National Centre for Infectious Diseases (NCID) or CDA will not be considered.
Fund Details
This fellowship does not cover visits to or from countries with travel advisories issued by the Ministry of Foreign Affairs.
Funding
Successful applicants will receive funding of up to S$10,000 per application. This sum will include:
Return economy airfare via the most direct route
Daily allowance
Airport transfer
Travel insurance and/or visa fees
Withholding tax (for incoming fellowships only)
Application procedure
Interested applicants are invited to complete pages [5] to [13] of the ‘CDA Short-Term Fellowship Application Form FY2026’, and submit (i) a single Microsoft Word document, without signatures, and (ii) a single PDF document, with signatures and supporting documents (e.g., quotations) through their Institutional Research Office to the grant secretariat (RCA_Grants@cda.gov.sg) by 6pm, 27 March 2026 (Friday).
Please contact the RCA Grant Secretariat for the application form.
Contact
RCA Grant Secretariat: RCA_Grants@cda.gov.sg
Additional Information
Funding will be disbursed strictly on a reimbursement basis. The timelines and submission requirements will be made known to successful applicants.
All visits must be completed before 31 January 2027. CDA will only reimburse claims for expenses incurred until the end of the visit. Reimbursement of funding claims will be made to the Applicant Institution.
All claims will be assessed in accordance with the travelling policy of the Applicant Institution. All claims must be certified by the Applicant Institution to be in accordance with its travelling policy.
FY2026 Short-Term Fellowship Awardees
FY2026 Short-Term Fellowship Awardees | |||
Awardee | Fellowship Type | Institution | Host/Destination |
Dr Marco Vignuzzi | Incoming | A*STAR | Dr Myrielle Dupont-Rouzeyrol, Institut Pasteur of New Caledonia |
Dr Chitra Panchapakesan | Outgoing | CDA | Prof Heidi Larson, London School of Hygiene & Tropical Medicine |
Dr Aw Yong Kam Leng | Outgoing | Duke-NUS | Prof Kobayashi Takeshi, University of Osaka, Japan |
Dr Carla Bianca Luena Victorio | Outgoing | Duke-NUS | Prof Gathsaurie Neelika Malavige, University of Sri Jayewardenepura, Sri Lanka |
Dr Joey Ming Er Lim | Outgoing | Duke-NUS | Dr Darunee Buddhari, WRAIR-AFRIMS, Thailand |
Dr Abhishek Senapati | Outgoing | NUS | Dr Wirichada Pan-Ngum, Mahidol University, Thailand |
Dr Clement Tsui Kin Ming | Outgoing | TTSH | Prof Paul E. Verweij, Radboud University Medical Centre, Netherlands |
